| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 01/08/2009 | US20090012310 reacting polymethine ether compound with an acid to produce polymethine compound containing a desired counter ion |
| 01/08/2009 | US20090012263 Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates |
| 01/08/2009 | US20090012246 Polymerization Catalyst Comprising Amidine Ligand |
| 01/08/2009 | US20090012147 2-(4-Chloro-2-oxo-2,3-dihydro-1H-indol-1-yl)acetamide; for treating, ameliorating, or inhibiting the effects of movement disorders and/or motor fluctuations in a subject suffering from Parkinson's disease |
| 01/08/2009 | US20090012145 Therapeutic esters |
| 01/08/2009 | US20090012134 Arylsulfonyl Benzofused Heterocycles as 5-Ht2a Antagonists |
| 01/08/2009 | US20090012120 Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines |
| 01/08/2009 | US20090012112 Alpha 1A-adrenoceptor antagonists |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | DE102006014324B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 01/08/2009 | DE102006014319B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 01/08/2009 | CA2692265A1 Amide compounds |
| 01/07/2009 | EP2011783A1 Process for the preparation of an indole derivative |
| 01/07/2009 | EP2010487A1 5-amido-2-carboxamide indoles |
| 01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/07/2009 | EP1771415B1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | CN101337921A Method for preparing 5-hydroxytryptamine from hippophae rhamnoides |
| 01/07/2009 | CN101337875A Beta-dione compounds with terminal vinyl group |
| 01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
| 01/06/2009 | US7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 01/06/2009 | US7473786 Preparing benzofurans or indoles by reacting an arylacetylene with an ortho-halo (especially iodo) phenol or aniline in the presence of a copper(1 ) complex with a bidentate ligand, e.g., copper(I) 1,10-phenanthroline bis(triphenylphosphine) nitrate; palladium-free |
| 01/06/2009 | US7473415 Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/01/2009 | US20090005594 Z=reacting Z-C(O) CH2 C(O)-Z ( Z= Cl)or HO C(O) CH2 (CO) OH and a carboxylic acid activating agent e.g. dicyclohexyl carbodiimide with a thiohydrazide compound ; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects |
| 01/01/2009 | US20090005572 Methods for preparing diazonamides |
| 01/01/2009 | US20090005429 Process for the preparation of carvedilol and its enantiomers |
| 01/01/2009 | US20090004506 Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives |
| 12/31/2008 | WO2009002761A1 A method for making n-2,3-dibromopropyl-4,5-dibromohexahydrophthalimide |
| 12/31/2008 | WO2009001817A1 COMPOUND HAVING 11β-HSD1 INHIBITORY ACTIVITY |
| 12/31/2008 | WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009000909A2 Salts of perindopril |
| 12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
| 12/31/2008 | WO2008053221A3 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 12/31/2008 | EP2008999A1 N-tert-butoxycarbonyl-2-pyrrolidinones and process for producing the same |
| 12/31/2008 | EP2007789A2 Hcv/hiv inhibitors and their uses |
| 12/31/2008 | EP2007721A2 A process for the purification of ropinirole hydrochloride |
| 12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| 12/31/2008 | EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/31/2008 | EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists |
| 12/31/2008 | CN101336262A Chromane substituted 2 -alkyl imidazopyridine derivatives and use thereof as acid pump antagonists |
| 12/31/2008 | CN101336232A 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids |
| 12/31/2008 | CN101336231A Methods for increasing the mean particle size of 2-hydrocarbyl-3,3-bis(hydroxyaryl)phthalimidines |
| 12/31/2008 | CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis |
| 12/31/2008 | CN101333439A Organic photoelectric functional material based on trisubstituted triindene structure unit and uses thereof |
| 12/31/2008 | CN101333183A Two-photon absorption material C60//C70 Fullerene-bonded carbazol derivates and method for preparing same |
| 12/31/2008 | CN101333182A Allyl-substituted earth-proof imide compound, liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display unit |
| 12/31/2008 | CN101333181A Novel crystalline forms of perindopril erbumine |
| 12/31/2008 | CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 12/31/2008 | CA2691849A1 Kallikrein 7 modulators |
| 12/31/2008 | CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470796 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
| 12/30/2008 | US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions |
| 12/30/2008 | CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 12/25/2008 | US20080319206 Process for Preparing Protected Amidines |
| 12/25/2008 | US20080319205 Process for preparing 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole |
| 12/25/2008 | US20080319204 Process for the synthesis of progesterone receptor modulators |
| 12/25/2008 | US20080319046 Substituted sulfonamide-indoles |
| 12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319043 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
| 12/25/2008 | US20080319040 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents |
| 12/25/2008 | US20080319031 Novel Tyrosine Derivatives |
| 12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
| 12/25/2008 | US20080318975 Prevent transplant rejection |
| 12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
| 12/25/2008 | US20080318923 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle |
| 12/25/2008 | US20080318874 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes |
| 12/25/2008 | US20080318776 2,6-Diethyl-4-Methylphenyl-Substituted Tetramic Acid Derivatives |
| 12/25/2008 | US20080318331 Anthraquinone Derivatives as Markers For Liquids |
| 12/25/2008 | US20080317744 Indole and Benzimidazole Derivatives |
| 12/25/2008 | US20080315754 Anthracene derivative and organic electroluminescence device using the same |
| 12/24/2008 | WO2009096126A1 Method for producing isoindole and isoindole produced by the method for producing isoindole |
| 12/24/2008 | WO2008157740A2 Faah inhibitors |
| 12/24/2008 | WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders |
| 12/24/2008 | WO2008156816A2 Renin inhibitors |
| 12/24/2008 | WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008156105A1 Organic electroluminescence element material, organic electroluminescence element, display device and illuminating device |
| 12/24/2008 | WO2008155594A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 12/24/2008 | WO2008155593A2 Phthalimide derivatives for labeling lipid droplets, and a method for visualization of cells and/or cellular organelles |
| 12/24/2008 | WO2008155421A2 Indolin-2-ones and aza-indolin-2-ones |
| 12/24/2008 | WO2008104597A3 Sulfonyltryptophanols |
| 12/24/2008 | EP2005500A1 Organic electronic devices using phthalimide compounds |
| 12/24/2008 | EP2004603A2 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use |
| 12/24/2008 | EP2004602A1 Salts with crth2 antagonist activity |
| 12/24/2008 | EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2008 | EP1651200B1 Galloylpeptides |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | EP1501503B1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 12/24/2008 | CN101331117A 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 12/24/2008 | CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds |
| 12/24/2008 | CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives |
| 12/24/2008 | CN101328145A Method for producing N- ethyl carbazole |
| 12/24/2008 | CN101328144A Method for synthesizing indoline and derivates thereof |
| 12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
| 12/24/2008 | CA2691522A1 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 12/24/2008 | CA2690410A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 12/24/2008 | CA2687909A1 Indolin-2-ones and aza-indolin-2-ones |